share_log

诺泰生物:收到中国证监会立案告知书

Neutai Biology: Received a notice of filing from the China Securities Regulatory Commission.

Breakings ·  Oct 23, 2024 17:25

Neutai Biology announcement, one of the company's actual controllers, Zhao Dezho, received a "Notice of Case Filing" from the China Securities Regulatory Commission for suspected violations of information disclosure laws and regulations. The case may involve the company's technology transfer matters for the year 2021. As of the announcement date, the company has not yet received the final investigation conclusion from the China Securities Regulatory Commission. The company will actively cooperate with the relevant work and fulfill its disclosure obligations. Currently, the company's operations are normal.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment